YungShin Global Holding Corp - Asset Resilience Ratio
YungShin Global Holding Corp (3705) has an Asset Resilience Ratio of 6.84% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 3705 total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2024)
This chart shows how YungShin Global Holding Corp's Asset Resilience Ratio has changed over time. See 3705 net asset value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down YungShin Global Holding Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of YungShin Global Holding Corp.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$819.17 Million | 6.84% |
| Total Liquid Assets | NT$819.17 Million | 6.84% |
Asset Resilience Insights
- Limited Liquidity: YungShin Global Holding Corp maintains only 6.84% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
YungShin Global Holding Corp Industry Peers by Asset Resilience Ratio
Compare YungShin Global Holding Corp's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Daihan Pharmaceutical Co.Ltd
KQ:023910 |
Drug Manufacturers - Specialty & Generic | 11.95% |
|
Aurobindo Pharma Limited
NSE:AUROPHARMA |
Drug Manufacturers - Specialty & Generic | 16.92% |
|
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
SHE:000999 |
Drug Manufacturers - Specialty & Generic | 5.22% |
|
Ningbo Menovo Pharm Co Ltd
SHG:603538 |
Drug Manufacturers - Specialty & Generic | 2.69% |
|
Zhejiang Xianju Pharmaceutical Co Ltd
SHE:002332 |
Drug Manufacturers - Specialty & Generic | 6.02% |
|
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365 |
Drug Manufacturers - Specialty & Generic | 30.38% |
|
Hainan Honz Pharmaceutical Co
SHE:300086 |
Drug Manufacturers - Specialty & Generic | 0.27% |
|
Guangdong Lifestrong Pharmacy Co. Ltd.
SHE:301111 |
Drug Manufacturers - Specialty & Generic | 7.85% |
Annual Asset Resilience Ratio for YungShin Global Holding Corp (2000–2024)
The table below shows the annual Asset Resilience Ratio data for YungShin Global Holding Corp.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 3.16% | NT$435.39 Million ≈ $13.72 Million |
NT$13.80 Billion ≈ $434.72 Million |
+0.37pp |
| 2023-12-31 | 2.79% | NT$321.13 Million ≈ $10.12 Million |
NT$11.51 Billion ≈ $362.70 Million |
+2.24pp |
| 2022-12-31 | 0.55% | NT$65.48 Million ≈ $2.06 Million |
NT$11.85 Billion ≈ $373.43 Million |
+0.01pp |
| 2021-12-31 | 0.55% | NT$65.48 Million ≈ $2.06 Million |
NT$12.01 Billion ≈ $378.36 Million |
-0.96pp |
| 2020-12-31 | 1.51% | NT$190.36 Million ≈ $6.00 Million |
NT$12.61 Billion ≈ $397.34 Million |
+1.31pp |
| 2019-12-31 | 0.20% | NT$24.75 Million ≈ $779.92K |
NT$12.36 Billion ≈ $389.39 Million |
-0.03pp |
| 2018-12-31 | 0.23% | NT$26.54 Million ≈ $836.22K |
NT$11.77 Billion ≈ $370.68 Million |
+0.53pp |
| 2017-12-31 | -0.30% | NT$-33.02 Million ≈ $-1.04 Million |
NT$11.02 Billion ≈ $347.14 Million |
+0.15pp |
| 2016-12-31 | -0.45% | NT$-45.43 Million ≈ $-1.43 Million |
NT$10.19 Billion ≈ $321.06 Million |
+0.53pp |
| 2015-12-31 | -0.97% | NT$-90.28 Million ≈ $-2.84 Million |
NT$9.26 Billion ≈ $291.90 Million |
-0.09pp |
| 2014-12-31 | -0.88% | NT$-76.55 Million ≈ $-2.41 Million |
NT$8.69 Billion ≈ $273.83 Million |
-1.24pp |
| 2013-12-31 | 0.36% | NT$29.62 Million ≈ $933.26K |
NT$8.23 Billion ≈ $259.25 Million |
-0.15pp |
| 2012-12-31 | 0.51% | NT$37.86 Million ≈ $1.19 Million |
NT$7.40 Billion ≈ $233.05 Million |
+0.20pp |
| 2011-12-31 | 0.31% | NT$22.73 Million ≈ $716.15K |
NT$7.32 Billion ≈ $230.52 Million |
-1.95pp |
| 2006-12-31 | 2.26% | NT$131.55 Million ≈ $4.14 Million |
NT$5.82 Billion ≈ $183.52 Million |
-4.52pp |
| 2005-12-31 | 6.78% | NT$394.55 Million ≈ $12.43 Million |
NT$5.82 Billion ≈ $183.41 Million |
+1.08pp |
| 2004-12-31 | 5.69% | NT$394.55 Million ≈ $12.43 Million |
NT$6.93 Billion ≈ $218.35 Million |
-2.96pp |
| 2003-12-31 | 8.66% | NT$565.01 Million ≈ $17.80 Million |
NT$6.53 Billion ≈ $205.65 Million |
+4.07pp |
| 2002-12-31 | 4.58% | NT$291.57 Million ≈ $9.19 Million |
NT$6.36 Billion ≈ $200.37 Million |
-0.01pp |
| 2001-12-31 | 4.60% | NT$288.00 Million ≈ $9.07 Million |
NT$6.26 Billion ≈ $197.35 Million |
+3.25pp |
| 2000-12-31 | 1.35% | NT$75.00 Million ≈ $2.36 Million |
NT$5.56 Billion ≈ $175.19 Million |
-- |
About YungShin Global Holding Corp
YungShin Global Holding Corporation, through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics. It is also involved in the sale of medicine; trade, investment, and other related businesses; import and export trading; and food manufacturing. The company operates in Taiwan, the United States, Mainland China, an… Read more